Mount Sinai Alzheimers Disease Expert Receives Lifetime Achievement Award
Alison M. Goate, PhD, Professor of Neuroscience, Genetics and Genomic Sciences and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai, has received the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research for the Alzheimer’s Association. The award was presented on July 19 during the opening session at the Alzheimer’s Association Conference ® 2015 (AAIC ® 2015) in Washington, DC. Dr. Goate received the award for her contribution to advancing Alzheimer’s disease and dementia research.
The AAIC Lifetime Achievement Awards honor individuals who have made significant fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. These contributions, whether they have been in research, leadership or mentorship, must have a lasting impact on the field and must demonstrate a lifetime commitment towards progress against Alzheimer’s and dementia.
“We are so proud of Dr. Goate and congratulate her for this outstanding honor,” said Eric J. Nestler, MD, PhD, Nash Family Professor and Chair of the Department of Neuroscience and Director of the Friedman Brain Institute in the Icahn School of Medicine at Mount Sinai. “Her internationally-recognized research to elucidate the genetic, molecular and cellular basis of Alzheimer’s disease and related dementias has added greatly to our understanding of these conditions. Under her leadership, Mount Sinai is playing a leading role in finding better treatments for Alzheimer’s and other disorders.”
Dr. Goate has worked on the genetics of Alzheimer’s disease for 27 years. She reported the first genetic mutation discovered that causes an inherited form of Alzheimer’s. She co-led the team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease.
“It is a great honor to receive this award from my peers in the Alzheimer’s disease research community,” said Dr. Goate. “This work has been a team effort over several decades, so this award recognizes the efforts of all of those individuals as well.”
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. They are committed to accelerating the global effort to eliminate Alzheimer’s disease and to recognizing the efforts of researchers who further our understanding about this devastating disease. The Association is the largest nonprofit funder of Alzheimer’s research. It currently supports nearly 350 ongoing research projects in 21 countries, totaling over $78 million. Since 1982, it has awarded nearly $340 million to almost 2,300 scientific investigations.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.